Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement

Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement

by Iftekhar Khan
Released November 2015
Publisher(s): Chapman and Hall/CRC
ISBN: 9781466505483

Read it now on the O’Reilly learning platform with a 10-day free trial.

O’Reilly members get unlimited access to books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.

Start your free trial

Book description

Economic evaluation has become an essential component of clinical trial design to show that new treatments and technologies offer value to payers in various healthcare systems. Although many books exist that address the theoretical or practical aspects of cost-effectiveness analysis, this book differentiates itself from the competition by detailing

Table of contents

  1. Front Cover (1/3)
  2. Front Cover (2/3)
  3. Front Cover (3/3)
  4. Contents (1/2)
  5. Contents (2/2)
  6. Preface
  7. Author
  8. Acronyms
  9. Chapter 1: Introduction to Economic Evaluation (1/5)
  10. Chapter 1: Introduction to Economic Evaluation (2/5)
  11. Chapter 1: Introduction to Economic Evaluation (3/5)
  12. Chapter 1: Introduction to Economic Evaluation (4/5)
  13. Chapter 1: Introduction to Economic Evaluation (5/5)
  14. Chapter 2: Health Economic Evaluation Concepts (1/6)
  15. Chapter 2: Health Economic Evaluation Concepts (2/6)
  16. Chapter 2: Health Economic Evaluation Concepts (3/6)
  17. Chapter 2: Health Economic Evaluation Concepts (4/6)
  18. Chapter 2: Health Economic Evaluation Concepts (5/6)
  19. Chapter 2: Health Economic Evaluation Concepts (6/6)
  20. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (1/7)
  21. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (2/7)
  22. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (3/7)
  23. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (4/7)
  24. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (5/7)
  25. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (6/7)
  26. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (7/7)
  27. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (1/7)
  28. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (2/7)
  29. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (3/7)
  30. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (4/7)
  31. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (5/7)
  32. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (6/7)
  33. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (7/7)
  34. Chapter 5: Quality of Life in Economic Evaluation (1/7)
  35. Chapter 5: Quality of Life in Economic Evaluation (2/7)
  36. Chapter 5: Quality of Life in Economic Evaluation (3/7)
  37. Chapter 5: Quality of Life in Economic Evaluation (4/7)
  38. Chapter 5: Quality of Life in Economic Evaluation (5/7)
  39. Chapter 5: Quality of Life in Economic Evaluation (6/7)
  40. Chapter 5: Quality of Life in Economic Evaluation (7/7)
  41. Chapter 6: Modelling in Economic Evaluation (1/6)
  42. Chapter 6: Modelling in Economic Evaluation (2/6)
  43. Chapter 6: Modelling in Economic Evaluation (3/6)
  44. Chapter 6: Modelling in Economic Evaluation (4/6)
  45. Chapter 6: Modelling in Economic Evaluation (5/6)
  46. Chapter 6: Modelling in Economic Evaluation (6/6)
  47. Chapter 7: Sensitivity Analyses (1/6)
  48. Chapter 7: Sensitivity Analyses (2/6)
  49. Chapter 7: Sensitivity Analyses (3/6)
  50. Chapter 7: Sensitivity Analyses (4/6)
  51. Chapter 7: Sensitivity Analyses (5/6)
  52. Chapter 7: Sensitivity Analyses (6/6)
  53. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (1/7)
  54. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (2/7)
  55. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (3/7)
  56. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (4/7)
  57. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (5/7)
  58. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (6/7)
  59. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (7/7)
  60. Chapter 9: Mixed Treatment Comparisons, Evidence Synthesis (1/3)
  61. Chapter 9: Mixed Treatment Comparisons, Evidence Synthesis (2/3)
  62. Chapter 9: Mixed Treatment Comparisons, Evidence Synthesis (3/3)
  63. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (1/6)
  64. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (2/6)
  65. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (3/6)
  66. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (4/6)
  67. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (5/6)
  68. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (6/6)
  69. Chapter 11: The Reimbursement Environment (1/3)
  70. Chapter 11: The Reimbursement Environment (2/3)
  71. Chapter 11: The Reimbursement Environment (3/3)
  72. References (1/2)
  73. References (2/2)
  74. Bibliography (1/2)
  75. Bibliography (2/2)
  76. Back Cover

Product information

  • Title: Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
  • Author(s): Iftekhar Khan
  • Release date: November 2015
  • Publisher(s): Chapman and Hall/CRC
  • ISBN: 9781466505483